Clinical Trials Sponsored by Francesco Vasile

Total 3421 results

University of Catania
Marinella Astuto; Carmelo Minardi; Mirko Mineri; Francesco Vasile; Gaetano Joseph...

Completed

Hemodynamic Monitoring in Obstetrics

Hypotension

Italy
Universidade Federal do vale do São Francisco

Enrolling by invitation

Effects of Capoeira on the Physical and Psychological Performance of Adults

Training | Mental Health | Physical Fitness

Brazil
Universidade Federal do vale do São Francisco

Completed

Stretching Isquiotibials in Water and on Land in Healthy Adutls (Flexibility)

Muscle Relaxation

Brazil
Universidade Federal do vale do São Francisco

Completed

Pilates Method on Functional Capacity and Blood Pressure of Elderly Women With Type 2 Diabetes

Blood Pressure | Physical Disability | Type-2 Diabetes
Universidade Federal do vale do São Francisco

Completed

Program of Physical, Nutritional and Psychological Activities With Overweight Schoolchildren (PANPES)

Cardiovascular Risk Factor
Universidade Federal do vale do São Francisco

Completed

Resistance Exercise Modify Cardiovascular Responses of Professors During Teaching and Sleep

Post-Exercise Hypotension
Universidade Federal do vale do São Francisco

Recruiting

Effectiveness Inspirational Muscle Training (IMTversusMV)

Respiratory Insufficiency

Brazil
Universidade Federal do vale do São Francisco

Completed

Exercise and Blood Pressure Reactivity

Hypertension

Brazil
Universidade Federal do vale do São Francisco

Recruiting

Effectiveness of Aquatic Exercises for Improving Mental and Physical Health in Adults. (AEforMH)

Depression | Anxiety | Depressive Symptoms

Brazil
Universidade Federal do vale do São Francisco

Completed

Essential Oil of Eucalyptus Effect on Cardiovascular Responses

Hypertension
University of California, San Francisco
Universidad del Valle, Guatemala

Completed

NACER II: Reducing Prenatal Exposures to Household Air Pollution in Rural Guatemala Through a Gas Stove/Behavior Intervention to Improve Neonatal Health

Premature Birth | Fetal Growth Retardation | Infant, Small for Gestational Age | Infections, Respiratory | Exposure to Environmental Pollution, Non-occupational

Guatemala
Clínica Basilea

Not yet recruiting

Measurement of the Diaphragm Loading During the Training With a IMT Device

Physical Therapy Modalities, Respiratory Muscles, Maximal Respiratory Pressures, Breathing Exercise
Basilea Pharmaceutica

Terminated

Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics

Bacterial Infections

United States, Belgium, Germany, Latvia, Lithuania, Poland
Basilea Pharmaceutica

Completed

Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections

Acute Bacterial Skin and Skin Structure Infections

United States, Bulgaria, Hungary, Ukraine
Basilea Pharmaceutica

Available

Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations

Intrahepatic Cholangiocarcinoma
Basilea Pharmaceutica

Completed

Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy

Acute Myeloid Leukemia

Germany
Basilea Pharmaceutica

Completed

Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis

Hand Dermatoses

Germany
Basilea Pharmaceutica

Completed

Alitretinoin in the Treatment of Chronic Hand Eczema

Eczema

France, Germany
Basilea Pharmaceutica

Completed

Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis

Hand Dermatoses

Germany
Vesale Pharmaceutica

Completed

Dietary Supplementation of Lactogyn in Women With Bacterial Vaginosis

Bacterial Vaginosis

Ukraine
Basilea Pharmaceutica

Withdrawn

Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia

Bacteremia
Basilea Pharmaceutica

Completed

Ceftobiprole in Hospital Acquired Pneumonia

Pneumonia
Basilea Pharmaceutica

Terminated

A Study of Ceftobiprole in Patients With Fever and Neutropenia.

Neutropenia | Fever | Gram-positive Bacterial Infections | Pseudomonas Infection
Basilea Pharmaceutica

Completed

Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU

ICU

United States, Belgium, Spain, Israel, Korea, Republic of, Canada
Basilea Pharmaceutica

Completed

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

Skin Diseases, Infectious | Staphylococcal Skin Infections | Skin Diseases, Bacterial
Basilea Pharmaceutica

Completed

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

Skin Diseases, Infectious | Staphylococcal Skin Infections | Skin Diseases, Bacterial
Basilea Pharmaceutica

Recruiting

Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age

Neonatal Sepsis

United States, Latvia, Lithuania, Poland, Slovakia, Bulgaria, Estonia, Germany
Basilea Pharmaceutica

Not yet recruiting

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis

Candidemia | Candidiasis, Invasive
Basilea Pharmaceutica

Completed

Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis

Hand Dermatoses

Poland, Germany, Canada
Basilea Pharmaceutica

Completed

An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors

Solid Organ Tumors

United Kingdom
Basilea Pharmaceutica

Completed

Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma

Neoplasms

Switzerland
Basilea Pharmaceutica

Completed

Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers

Streptococcal Infections | Staphylococcal Skin Infections
Basilea Pharmaceutica

Completed

Effect of Ceftobiprole on Human Intestinal Microflora

Drug Resistance | Antimicrobial Agent | Cephalosporins
Basilea Pharmaceutica

Terminated

Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia

Ventilator Associated Pneumonia
Basilea Pharmaceutica

Active, not recruiting

A Clinical Trial of the Study Medicine (Called Fosmanogepix) in People With Hepatic Dysfunction.

Hepatic Impairment

United States
Basilea Pharmaceutica

Terminated

Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma (FIDES-03)

Gastric Adenocarcinoma

Spain, United States, Korea, Republic of, Belgium, Russian Federation, United Kingdom, Italy, France, Turkey, Germany, Poland, Brazil, Australia, Argentina, Chile
Basilea Pharmaceutica

Completed

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma (FIDES-01)

Intrahepatic Cholangiocarcinoma | Combined Hepatocellular and Cholangiocarcinoma

Canada, United States, Spain, Belgium, Italy, Korea, Republic of, Germany, Switzerland, France, United Kingdom, Ireland
Basilea Pharmaceutica

Completed

Derazantinib and Atezolizumab in Patients With Urothelial Cancer (FIDES-02)

Urothelial Carcinoma

United Kingdom, Korea, Republic of, Italy, Canada, France, Spain, Germany, United States, Hungary, Australia, Poland, Switzerland, Czechia, Austria
Basilea Pharmaceutica

Completed

Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia

Community-acquired Pneumonia (CAP) | Hospital-acquired Pneumonia (HAP)

Bulgaria, Hungary, Georgia, Romania
Basilea Pharmaceutica

Completed

Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma

Neoplasms

Belgium, United Kingdom, Germany, Switzerland
Basilea Pharmaceutica

Completed

Mass Balance and Pharmacokinetics Study of Derazantinib in Healthy Male Subjects

Healthy Volunteers

United Kingdom
Basilea Pharmaceutica

Completed

Ceftobiprole in Hospital Acquired Pneumonia

Pneumonia
Basilea Pharmaceutica

Completed

Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia

Pneumonia
Basilea Pharmaceutica

Completed

Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone

Total Hip Replacement Surgery
Kastle Therapeutics, LLC

Completed

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol (FOCUS FH)

Hypercholesterolemia | Heterozygous Familial

United States, Italy, Poland, Ukraine, United Kingdom, Germany, Hong Kong, Taiwan, Spain, Argentina, Belgium, Israel, Malaysia, South Africa, Turkey, Netherlands, Korea, Republic of, Canada, New Zealand, Russian Federation, Brazil, Austral... and more
Agile Therapeutics

Completed

Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System

Healthy
Agile Therapeutics

Completed

Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers

Healthy

United States
Agile Therapeutics

Completed

Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm (ATI-CL13)

Contraception

United States
Castle Biosciences Incorporated

Completed

5 Year Registry Study to Track Clinical Application of DecisionDx-UM Assay Results and Associated Patient Outcomes (CLEAR)

Uveal Melanoma
Castle Biosciences Incorporated

Terminated

5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results (INTEGRATE)

Cutaneous Melanoma

United States

Clinical Trials Sponsored by Francesco Vasile

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations